Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuhong Zeng

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
JAMA Network Open|August 16, 2021
Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence StudyLinhong Wang, Wei Yu, Xiangjun Yin, et al.
Journal of Orthopaedic Translation|May 25, 2026
Efficacy of once-weekly teriparatide versus alendronate in Chinese postmenopausal osteoporosis: a randomised, open-label, active-controlled, 48-week, multicentre phase III studyJiemei Gu, Aijun Chao, Yanan Huo, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
JAMA Network Open|August 16, 2021
Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence StudyLinhong Wang, Wei Yu, Xiangjun Yin, et al.
Journal of Orthopaedic Translation|May 25, 2026
Efficacy of once-weekly teriparatide versus alendronate in Chinese postmenopausal osteoporosis: a randomised, open-label, active-controlled, 48-week, multicentre phase III studyJiemei Gu, Aijun Chao, Yanan Huo, et al.
Pageof 9